Both in Pharmaceuticals
NextCure vs BeyondSpring
Over the past year NXTC returned −48.9% and BYSI returned −69.5%; their daily moves had a correlation of -0.01.
NXTC −48.9% BYSI −69.5%Growth of $1, one year, split-adjusted
| Metric | NXTC | BYSI |
|---|---|---|
| Price | $5.53 | $0.5300 |
| Market cap | $25.3M | $21.8M |
| Today | −2.56% | +3.33% |
| 1 month | +1.2% | −28.4% |
| 6 months | −49.6% | −69.5% |
| Year to date | −61.1% | −67.5% |
| 1 year | −53.7% | −70.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.1M | $6.5M |
| Dividend yield | — | — |
| Volatility (60d) | 129.7% | 154.6% |
| Short % of float | 8.1% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).